von Mikecz Anna, Schikowski Tamara
IUF-Leibniz Research Institute for Environmental Medicine gGmbH, Heinrich-Heine-University, 40225 Duesseldorf, Germany.
Nanomaterials (Basel). 2020 Jul 10;10(7):1349. doi: 10.3390/nano10071349.
How the environment contributes to neurodegenerative diseases such as Alzheimer's is not well understood. In recent years, science has found augmenting evidence that nano-sized particles generated by transport (e.g., fuel combustion, tire wear and brake wear) may promote Alzheimer's disease (AD). Individuals residing close to busy roads are at higher risk of developing AD, and nanomaterials that are specifically generated by traffic-related processes have been detected in human brains. Since AD represents a neurodegenerative disease characterized by amyloid protein aggregation, this review summarizes our current knowledge on the amyloid-generating propensity of traffic-related nanomaterials. Certain nanoparticles induce the amyloid aggregation of otherwise soluble proteins in in vitro laboratory settings, cultured neuronal cells and vertebrate or invertebrate animal models. We discuss the challenges for future studies, namely, strategies to connect the wet laboratory with the epidemiological data in order to elucidate the molecular bio-interactions of airborne nanomaterials and their effects on human health.
环境如何导致诸如阿尔茨海默病等神经退行性疾病,目前还不太清楚。近年来,科学发现越来越多的证据表明,交通产生的纳米级颗粒(如燃料燃烧、轮胎磨损和刹车磨损)可能会促进阿尔茨海默病(AD)的发展。居住在繁忙道路附近的个体患AD的风险更高,并且在人类大脑中已经检测到与交通相关过程专门产生的纳米材料。由于AD是一种以淀粉样蛋白聚集为特征的神经退行性疾病,本综述总结了我们目前对与交通相关的纳米材料产生淀粉样蛋白倾向的认识。某些纳米颗粒在体外实验室环境、培养的神经元细胞以及脊椎动物或无脊椎动物模型中会诱导原本可溶的蛋白质发生淀粉样聚集。我们讨论了未来研究面临的挑战,即如何将湿实验室研究与流行病学数据联系起来,以阐明空气中纳米材料的分子生物相互作用及其对人类健康的影响。